TSE:4502Pharmaceuticals
Takeda Pharmaceutical (TSE:4502) Wins FDA Approval For ORZEYFUL, Is The Stock Still Cheap?
Takeda Pharmaceutical (TSE:4502) is back in focus after the U.S. Food and Drug Administration approved ORZEYFUL, a first in class oral orexin receptor agonist for adults with narcolepsy type 1.
See our latest analysis for Takeda Pharmaceutical.
The FDA approval of ORZEYFUL has arrived alongside building momentum in Takeda Pharmaceutical's stock, with a 1 day share price return of 3.43% and a year to date share price return of 15.99%. The 1 year total shareholder return of 31.54% points to...